Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Palese

Showing results (151-160 of 291) with videos related to

Pageof 30
Sort By:
NPJ Vaccines|July 26, 2019
A mosaic hemagglutinin-based influenza virus vaccine candidate protects mice from challenge with divergent H3N2 strainsFelix Broecker, Sean T H Liu, Nungruthai Suntronwong, et al.
Viruses|October 26, 2021
Interaction between NS1 and Cellular MAVS Contributes to NS1 Mitochondria TargetingYeu-Yang Tseng, Chih-Ying Kuan, Masaki Mibayashi, et al.
Journal of Virology|November 2, 2018
Antibody Responses toward the Major Antigenic Sites of Influenza B Virus Hemagglutinin in Mice, Ferrets, and HumansWeina Sun, Davina S Kang, Allen Zheng, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 12, 2009
Enhancement of oncolytic properties of recombinant newcastle disease virus through antagonism of cellular innate immune responsesDmitriy Zamarin, Luis Martínez-Sobrido, Kaitlyn Kelly, et al.
Head & Neck|September 20, 2011
Therapeutic effects of a fusogenic newcastle disease virus in treating head and neck cancerPingdong Li, Chun-Hao Chen, Sen Li, et al.
Journal of Virology|March 9, 2012
Influenza viruses expressing chimeric hemagglutinins: globular head and stalk domains derived from different subtypesRong Hai, Florian Krammer, Gene S Tan, et al.
Mbio|September 21, 2017
Influenza Virus Hemagglutinin Stalk-Specific Antibodies in Human Serum are a Surrogate Marker for <i>In Vivo</i> Protection in a Serum Transfer Mouse Challenge ModelHenning Jacobsen, Madhusudan Rajendran, Angela Choi, et al.
Journal of Virology|June 14, 2003
Activation of tumor antigen-specific cytotoxic T lymphocytes (CTLs) by human dendritic cells infected with an attenuated influenza A virus expressing a CTL epitope derived from the HER-2/neu proto-oncogeneClay L Efferson, Jeanne Schickli, Byung Kyum Ko, et al.
Frontiers in Bioengineering and Biotechnology|June 21, 2023
Bioprocess development for universal influenza vaccines based on inactivated split chimeric and mosaic hemagglutinin virusesEduard Puente-Massaguer, Annika Beyer, Madhumathi Loganathan, et al.
Frontiers in Immunology|October 4, 2021
Mosaic Hemagglutinin-Based Whole Inactivated Virus Vaccines Induce Broad Protection Against Influenza B Virus Challenge in MiceYonghong Liu, Shirin Strohmeier, Irene González-Domínguez, et al.
Pageof 30

Showing results (151-160 of 291) with videos related to

Sort By:
Pageof 30
NPJ Vaccines|July 26, 2019
A mosaic hemagglutinin-based influenza virus vaccine candidate protects mice from challenge with divergent H3N2 strainsFelix Broecker, Sean T H Liu, Nungruthai Suntronwong, et al.
Viruses|October 26, 2021
Interaction between NS1 and Cellular MAVS Contributes to NS1 Mitochondria TargetingYeu-Yang Tseng, Chih-Ying Kuan, Masaki Mibayashi, et al.
Journal of Virology|November 2, 2018
Antibody Responses toward the Major Antigenic Sites of Influenza B Virus Hemagglutinin in Mice, Ferrets, and HumansWeina Sun, Davina S Kang, Allen Zheng, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 12, 2009
Enhancement of oncolytic properties of recombinant newcastle disease virus through antagonism of cellular innate immune responsesDmitriy Zamarin, Luis Martínez-Sobrido, Kaitlyn Kelly, et al.
Head & Neck|September 20, 2011
Therapeutic effects of a fusogenic newcastle disease virus in treating head and neck cancerPingdong Li, Chun-Hao Chen, Sen Li, et al.
Journal of Virology|March 9, 2012
Influenza viruses expressing chimeric hemagglutinins: globular head and stalk domains derived from different subtypesRong Hai, Florian Krammer, Gene S Tan, et al.
Mbio|September 21, 2017
Influenza Virus Hemagglutinin Stalk-Specific Antibodies in Human Serum are a Surrogate Marker for <i>In Vivo</i> Protection in a Serum Transfer Mouse Challenge ModelHenning Jacobsen, Madhusudan Rajendran, Angela Choi, et al.
Journal of Virology|June 14, 2003
Activation of tumor antigen-specific cytotoxic T lymphocytes (CTLs) by human dendritic cells infected with an attenuated influenza A virus expressing a CTL epitope derived from the HER-2/neu proto-oncogeneClay L Efferson, Jeanne Schickli, Byung Kyum Ko, et al.
Frontiers in Bioengineering and Biotechnology|June 21, 2023
Bioprocess development for universal influenza vaccines based on inactivated split chimeric and mosaic hemagglutinin virusesEduard Puente-Massaguer, Annika Beyer, Madhumathi Loganathan, et al.
Frontiers in Immunology|October 4, 2021
Mosaic Hemagglutinin-Based Whole Inactivated Virus Vaccines Induce Broad Protection Against Influenza B Virus Challenge in MiceYonghong Liu, Shirin Strohmeier, Irene González-Domínguez, et al.
Pageof 30